WHO ICTRP trial
Red-light therapy for highly myopic children
JPRN-jRCTs032220339 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCTs032220339 |
|---|---|
| Public title | Red-light therapy for highly myopic children |
| Scientific title | Repeated low-level red-light therapy for shortening axial length in high myopia children and teenagers: a prospective, single-arm study - Repeated low-level red-light therapy shortens axial length |
| Primary sponsor | Ohno Kyoko |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2-3 |
| Conditions | High Myopia Nearsightedness, High myopia, Children,;D009216;Nearsightedness, High myopia, Children, |
| Interventions | Red light treatment is performed for 12 months using the research device Eyerising Myopia Management Device. Red light therapy is phototherapy using low power red light at 650 nm. Subjects will be treated with a therapy device twice a day… |
| Registration date | Sep 20, 2022 |
| Target size | 30 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: